Skip to content
Family HoldingPuts its own capital into companiesActive · deal in last 18 monthsLAST VERIFIED Oct 2026 · 25 SOURCES

Jacobs Capital

Also known as Jacobs Holding, Jacobs Holding AG, Telemos Capital, Jacobs Capital U.K. Limited

Jacobs family investment firm (London, Zurich, Luxembourg) formed in 2025 from Jacobs Holding and Telemos Capital; takes control stakes of €100–300M in European mid-market companies.

USEFUL FOR Business owners seeking a long-term partner · Co-investors

Investment firm of the Jacobs family (Jacobs coffee / Jacobs Suchard heritage), formed in June 2025 by combining Jacobs Holding (Zurich, founded 1994) and Telemos Capital (London, founded 2017). Not the Jacobs Foundation, from which Jacobs Holding separated in April 2025.

Family & background

FAMILY
Jacobs
WEALTH ORIGIN
Coffee and confectionery (Jacobs; Jacobs Suchard AG, sold 1990)
HEADQUARTERS
London, United Kingdom
FOUNDED
2025
OUTSIDE CAPITAL
No — own capital only

Investment approach

SECTORS
Consumer & E-commerceEducationHealthTech
GEOGRAPHY
Europe
STAGES
Buyout
ROUTES
Companies (own capital)
STRATEGIES
Direct investmentsPrivate equity
TICKET
€100M–€300M
LATEST DEAL
Oak Fund Services (Add-on: acquisition by portfolio company Highvern & Permian, backed by Jacobs Capital) · Jun 2026

Overview

Jacobs Capital was formed in June 2025 when Jacobs Holding (founded in Zurich in 1994, after the family sold Jacobs Suchard AG in 1990) and Telemos Capital (founded in London in 2017) combined. It invests private, evergreen family capital under the stewardship of co-chairmen Philippe and Nicolas Jacobs, separately from the Jacobs Foundation. The firm targets equity deployments of €100–300 million per investment, taking control or co-control stakes in cash-generative mid-market companies in business services, consumer, education and healthcare, with offices in London, Zurich and Luxembourg. Companies listed on its site include Barry Callebaut, Cognita, Colosseum Dental, Helios, iLERNA, Lovehoney Group, Mammut, MaxBau, North American Dental Group, Highvern / Permian and Vittoria; Stingray Healthcare, MedEuropa and Sanoptis are shown as realised.

Investment thesis

Control or co-control investments in high-performing, cash-flow generative European mid-market companies in business services, consumer, education and healthcare, grown through international expansion, add-on acquisitions and operational improvement; medium-term holds with flexibility to hold longer.

Holdings & investments (14)

  • CognitaNOTABLE
    Education · since 2018
  • Barry CallebautNOTABLE
    Consumer & E-commerce · since 1983
  • Colosseum Dental GroupNOTABLE
    HealthTech · since 2017
  • iLERNA
    Education · since 2024
  • Highvern / Permian
    since 2024
  • Helios Global Group
    HealthTech · since 2024
  • Vittoria
    Consumer & E-commerce · since 2022 · Majority stake
  • Mammut
    Consumer & E-commerce · since 2021 · Sale to CPE agreed July 2026
  • MaxBau
    Industrial & Manufacturing · since 2019
  • North American Dental Group
    HealthTech · since 2019
  • Lovehoney Group
    Consumer & E-commerce · since 2018
  • Sanoptis
    HealthTech · since 2018 · Exited 2022
  • Stingray Healthcare
    HealthTech · since 2018 · Exited 2025
  • MedEuropa Romania
    HealthTech · since 2018 · Exited 2024

People

  • Jacob Polny
    CEO / CIO · source
  • Philippe Jacobs
    Co-Chairman · source
  • Nicolas Jacobs
    Co-Chairman · source
  • Rafael Zemp
    Group CFO · source
  • Sami Kassam
    Managing Director · source
  • Johan Pettersson
    Director, Head of Business Services · source
  • Eric Stöcklin
    Director · source
  • Bertrand Fontaine
    Director · source
  • Guy Alexios Danon
    Director · source

Frequently asked questions

Jacobs Capital is a family holding based in London, the United Kingdom, founded in 2025.

Jacobs Capital invests on behalf of the Jacobs family (Coffee and confectionery (Jacobs; Jacobs Suchard AG, sold 1990)).

Jacobs Capital invests its own capital into companies. Its stated asset mix includes direct investments and private equity.

Jacobs Capital invests at Buyout stage in Consumer & E-commerce, Education and HealthTech.

Jacobs Capital's stated ticket size is €100M–€300M.

Key people at Jacobs Capital include Philippe Jacobs (Co-Chairman), Nicolas Jacobs (Co-Chairman), Jacob Polny (CEO / CIO) and Rafael Zemp (Group CFO).

Jacobs Capital's holdings and investments include Cognita, Barry Callebaut, Colosseum Dental Group, iLERNA, Lovehoney Group, Mammut, Highvern / Permian and Helios Global Group, among others.

The most recent publicly reported investment by Jacobs Capital is Oak Fund Services (Add-on: acquisition by portfolio company Highvern & Permian, backed by Jacobs Capital), announced in Jun 2026.

No. Jacobs Capital invests its own capital and does not raise money from outside investors.